Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus.
Epilepsia
; 61(10): e135-e139, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-780863
ABSTRACT
There have been multiple descriptions of seizures during the acute infectious period in patients with COVID-19. However, there have been no reports of status epilepticus after recovery from COVID-19 infection. Herein, we discuss a patient with refractory status epilepticus 6 weeks after initial infection with COVID-19. Extensive workup demonstrated elevated inflammatory markers, recurrence of a positive nasopharyngeal SARS-CoV-2 polymerase chain reaction, and hippocampal atrophy. Postinfectious inflammation may have triggered refractory status epilepticus in a manner similar to the multisystemic inflammatory syndrome observed in children after COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Status Epilepticus
/
COVID-19
/
Inflammation
Type of study:
Case report
Topics:
Long Covid
Limits:
Aged
/
Female
/
Humans
Language:
English
Journal:
Epilepsia
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS